Advanced search
Publication Cover
Emerging Microbes & Infections Volume 9, 2020 - Issue 1
Submit an article Journal homepage
20,334
Views
355
CrossRef citations to date
0
Altmetric
Articles

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists

Chun-Kit Yuena State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-2646-2054
ORCID Icon,
Joy-Yan Lama State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China
,
Wan-Man Wonga State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China
,
Long-Fung Maka State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China
,
Xiaohui Wanga State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China
,
Hin Chua State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;c Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China
,
Jian-Piao Caia State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;c Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China
,
Dong-Yan Jind School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-2778-3530
ORCID Icon,
Kelvin Kai-Wang Toa State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;c Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;e Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of China;f Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-1921-5824
ORCID Icon,
Jasper Fuk-Woo Chana State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;c Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;e Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of China;f Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China
,
Kwok-Yung Yuena State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;c Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;e Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of China;f Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaCorrespondence[email protected]
&
Kin-Hang Koka State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;b Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of China;c Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3426-332X
ORCID Icon show all
Pages 1418-1428 | Received 07 May 2020, Accepted 07 Jun 2020, Published online: 20 Jun 2020

Citations (355)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (21)

Despina D. Briana, Anna Papadopoulou, Garyfallia Syridou, Edoardo Marchisio, Eleni Kapsabeli, Anna Daskalaki & Vassiliki Papaevangelou. (2024) Early human milk lactoferrin during SARS-CoV-2 infection. The Journal of Maternal-Fetal & Neonatal Medicine 35:25, pages 6704-6707.
Read now
Cody J. Bills, Hongjie Xia, John Yun-Chung Chen, Jason Yeung, Birte K. Kalveram, David Walker, Xuping Xie & Pei-Yong Shi. (2023) Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism. Emerging Microbes & Infections 12:1.
Read now
Reza Elahi, Salar Hozhabri, Amirhosein Moradi, Amir Siahmansouri, Armin Jahani Maleki & Abdolreza Esmaeilzadeh. (2023) Targeting the cGAS-STING pathway as an inflammatory crossroad in coronavirus disease 2019 (COVID-19). Immunopharmacology and Immunotoxicology 45:6, pages 639-649.
Read now
S. Swathi Krishna, M. S. Sudheesh & Vidya Viswanad. (2023) Liposomal drug delivery to the lungs: a post covid-19 scenario. Journal of Liposome Research 33:4, pages 410-424.
Read now
Dennis Jiménez & Marbel Torres Arias. (2022) Immunouniverse of SARS-CoV-2. Immunological Medicine 45:4, pages 186-224.
Read now
Qian Wang, Xing Wu, Qunying Mao, Fan Gao, Mingchen Liu, Ziyang Song, Lianlian Bian & Zhenglun Liang. (2022) How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review. Expert Review of Anti-infective Therapy 20:8, pages 1119-1127.
Read now
M. Elizabeth Sobhia, Ketan Ghosh, Srikanth Sivangula, Siva Kumar & Harmanpreet Singh. (2022) Identification of potential SARS-CoV-2 Mpro inhibitors integrating molecular docking and water thermodynamics. Journal of Biomolecular Structure and Dynamics 40:11, pages 5079-5089.
Read now
Sam Horrell, Gianluca Santoni & Andrea Thorn. (2022) Structural biology of SARS-CoV-2 endoribonuclease NendoU (nsp15). Crystallography Reviews 28:1, pages 4-20.
Read now
Rameez Jabeer Khan, Rajat Kumar Jha, Ekampreet Singh, Monika Jain, Gizachew Muluneh Amera, Rashmi Prabha Singh, Jayaraman Muthukumaran & Amit Kumar Singh. (2022) Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study. Journal of Biomolecular Structure and Dynamics 40:1, pages 438-448.
Read now
Bushra Mdkhana, Narjes Saheb Sharif-Askari, Rakhee K Ramakrishnan, Swati Goel, Qutayba Hamid & Rabih Halwani. (2021) Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality. Journal of Inflammation Research 14, pages 199-216.
Read now
Nicholas Evans, Edgar Martinez, Nicola Petrosillo, Jacob Nichols, Ebtesam Islam, Kevin Pruitt & Sharilyn Almodovar. (2021) SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack. HIV/AIDS - Research and Palliative Care 13, pages 361-375.
Read now
Austin N. Spratt, Fabio Gallazzi, Thomas P. Quinn, Christian L. Lorson, Anders Sönnerborg & Kamal Singh. (2021) Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents. Expert Opinion on Therapeutic Patents 31:4, pages 339-350.
Read now
Maricar Malinis, Dayna McManus, Matthew Davis & Jeffrey Topal. (2021) An overview on the use of antivirals for the treatment of patients with COVID19 disease. Expert Opinion on Investigational Drugs 30:1, pages 45-59.
Read now
Xiaohui Wang, Joy-Yan Lam, Linlei Chen, Shannon Wing-Ngor Au, Kelvin K. W. To, Kwok-Yung Yuen & Kin-Hang Kok. (2021) Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients. Emerging Microbes & Infections 10:1, pages 1016-1023.
Read now
Kelvin Kai-Wang To, Siddharth Sridhar, Kelvin Hei-Yeung Chiu, Derek Ling-Lung Hung, Xin Li, Ivan Fan-Ngai Hung, Anthony Raymond Tam, Tom Wai-Hin Chung, Jasper Fuk-Woo Chan, Anna Jian-Xia Zhang, Vincent Chi-Chung Cheng & Kwok-Yung Yuen. (2021) Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerging Microbes & Infections 10:1, pages 507-535.
Read now
Serena Delbue, Sarah D’Alessandro, Lucia Signorini, Maria Dolci, Elena Pariani, Michele Bianchi, Stefania Fattori, Annalisa Modenese, Cristina Galli, Ivano Eberini & Pasquale Ferrante. (2021) Isolation of SARS-CoV-2 strains carrying a nucleotide mutation, leading to a stop codon in the ORF 6 protein. Emerging Microbes & Infections 10:1, pages 252-255.
Read now
Grégory Quéromès, Grégory Destras, Antonin Bal, Hadrien Regue, Gwendolyne Burfin, Solenne Brun, Rémi Fanget, Florence Morfin, Martine Valette, Sophie Trouillet-Assant, Bruno Lina, Emilie Frobert & Laurence Josset. (2021) Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France. Emerging Microbes & Infections 10:1, pages 167-177.
Read now
Ronan Garlantézec, Christopher Heslan, Emilie Tadie, Pierre Tattevin, Vincent Thibault & Christophe Paris. (2020) A lateral flow immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workers. Emerging Microbes & Infections 9:1, pages 2547-2549.
Read now
Joy-Yan Lam, Chun-Kit Yuen, Jonathan Daniel Ip, Wan-Man Wong, Kelvin Kai-Wang To, Kwok-Yung Yuen & Kin-Hang Kok. (2020) Loss of orf3b in the circulating SARS-CoV-2 strains. Emerging Microbes & Infections 9:1, pages 2685-2696.
Read now
Prapaporn Srilohasin, Therdsak Prammananan, Kiatichai Faksri, Jody E. Phelan, Prapat Suriyaphol, Phalin Kamolwat, Saijai Smithtikarn, Areeya Disratthakit, Sanjib Mani Regmi, Manoon Leechawengwongs, Rick Twee-Hee Ong, Yik Ying Teo, Sissades Tongsima, Taane G. Clark & Angkana Chaiprasert. (2020) Genomic evidence supporting the clonal expansion of extensively drug-resistant tuberculosis bacteria belonging to a rare proto-Beijing genotype. Emerging Microbes & Infections 9:1, pages 2632-2641.
Read now
Tuba N. Gide, Ines P. Silva, Camelia Quek, Tasnia Ahmed, Alexander M. Menzies, Matteo S. Carlino, Robyn P.M. Saw, John F. Thompson, Marcel Batten, Georgina V. Long, Richard A. Scolyer & James S. Wilmott. (2020) Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients. OncoImmunology 9:1.
Read now

Articles from other publishers (334)

Carolyn Krause, Eva Bergmann & Susanne Viktoria Schmidt. (2024) Epigenetic modulation of myeloid cell functions in HIV and SARS-CoV-2 infection. Molecular Biology Reports 51:1.
Crossref
Evangelos Andreakos. (2024) Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond. Seminars in Immunology 72, pages 101863.
Crossref
Yingjie Xiang, Chunxiao Mou, Liqi Zhu, Ziyan Wang, Kaichuang Shi, Wenbin Bao, Jiarui Li, Xiang Chen & Zhenhai Chen. (2024) SADS-CoV nsp1 inhibits the STAT1 phosphorylation by promoting K11/K48-linked polyubiquitination of JAK1 and blocks the STAT1 acetylation by degrading CBP. Journal of Biological Chemistry 300:3, pages 105779.
Crossref
Sk. Sarif Hassan, Tanishta Bhattacharya, Debaleena Nawn, Ishana Jha, Pallab Basu, Elrashdy M. Redwan, Kenneth Lundstrom, Debmalya Barh, Bruno Silva Andrade, Murtaza M. Tambuwala, Alaa A. Aljabali, Altijana Hromić-Jahjefendić, Wagner Baetas-da-Cruz, Ángel Serrano-Aroca & Vladimir N. Uversky. (2024) SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants. Computers in Biology and Medicine 170, pages 107899.
Crossref
Haixin Huang, Xiaoxiao Lei, Chenchen Zhao, Yan Qin, Yuying Li, Xinyu Zhang, Chengkai Li, Tian Lan, Baopeng Zhao, Wenchao Sun, Huijun Lu & Ningyi Jin. (2024) Porcine deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving IFIT3. Journal of Virology 98:2.
Crossref
Linran Zhang, Pengfei Hao, Xiang Chen, Shuai Lv, Wenying Gao, Chang Li, Zhaolong Li & Wenyan Zhang. (2024) CRL4B E3 ligase recruited by PRPF19 inhibits SARS-CoV-2 infection by targeting ORF6 for ubiquitin-dependent degradation. mBio 15:2.
Crossref
Fahime Edalat, Niloofar Khakpour, Hossein Heli, Arash Letafati, Amin Ramezani, Seyed Younes Hosseini & Afagh Moattari. (2024) Immunological mechanisms of the nucleocapsid protein in COVID-19. Scientific Reports 14:1.
Crossref
Elena Krachmarova, Peicho Petkov, Elena Lilkova, Dayana Stoynova, Kristina Malinova, Rossitsa Hristova, Anastas Gospodinov, Nevena Ilieva, Genoveva Nacheva & Leandar Litov. (2024) Interferon-γ as a Potential Inhibitor of SARS-CoV-2 ORF6 Accessory Protein. International Journal of Molecular Sciences 25:4, pages 2155.
Crossref
Wenying Gao, Liuli Wang, Wenzhe Cui, Hongfei Wang, Guofeng Huang, Zhaolong Li, Guangquan Li & Wenyan Zhang. (2024) Deubiquitinase USP1 regulates sarbecovirus ORF6 protein function. Journal of Virology 98:1.
Crossref
Tae Yeon Yoo & Timothy J. Mitchison. (2024) Quantitative comparison of nuclear transport inhibition by SARS coronavirus ORF6 reveals the importance of oligomerization. Proceedings of the National Academy of Sciences 121:4.
Crossref
Marília Inês Móvio, Giovana Waner Carneiro de Almeida, Isabella das Graças Lopes Martines, Gilmara Barros de Lima, Sergio Daishi Sasaki, Alexandre Hiroaki Kihara, Emma Poole, Michael Nevels & Maria Cristina Carlan da Silva. (2024) SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms. Viruses 16:1, pages 161.
Crossref
Wenkai Li, Yunjing Zhuang, Song-Jun Shao, Pankaj Trivedi, Biying Zheng, Guo-Liang Huang, Zhiwei He & Xiangning Zhang. (2024) Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses and pathogenesis of COVID‑19 (Review). Molecular Medicine Reports 29:3.
Crossref
Silvio Steiner, Annika Kratzel, G. Tuba Barut, Reto M. Lang, Etori Aguiar Moreira, Lisa Thomann, Jenna N. Kelly & Volker Thiel. (2024) SARS-CoV-2 biology and host interactions. Nature Reviews Microbiology.
Crossref
Chiu Wang Chau & Ryohichi Sugimura. (2024) Organoids in COVID-19: can we break the glass ceiling?. Journal of Leukocyte Biology 115:1, pages 85-99.
Crossref
Aarthi Goverdhan. 2024. Textbook of SARS-CoV-2 and COVID-19. Textbook of SARS-CoV-2 and COVID-19 24 51 .
Niraj Kumar Singh, Anuj Tyagi, Balasubramanian Ganesh, Rahul Kaushik, Mohamed E. El Zowalaty, Kuldeep Dhama & Yashpal Singh Malik. 2024. Molecular Medical Microbiology. Molecular Medical Microbiology 2683 2696 .
Zhiqiang Xu, Mingyao Tian, Qihan Tan, Pengfei Hao, Zihan Gao, Chang Li & Ningyi Jin. (2023) FHL2 Inhibits SARS-CoV-2 Replication by Enhancing IFN-β Expression through Regulating IRF-3. International Journal of Molecular Sciences 25:1, pages 353.
Crossref
Nick A Francis, Phillip D Monk, Jacqueline Nuttall, Thomas Oliver, Catherine Simpson, Jody L Brookes, Victoria J Tear, Angela G Thompson, Toby N Batten, Marcin Mankowski & Thomas MA Wilkinson. (2023) Feasibility of home administration of nebulised interferon ß-1a (SNG001) for COVID-19: a remote study. BJGP Open 7:4, pages BJGPO.2023.0089.
Crossref
Rafael Peñuela, Indira Hernandez, Mónica Fernandes-Pineda, Lázaro Cortina, Diana Zapata, Olga Urrego, Juan Herrera, Isabel Saenz, Recio Orduz, Fabián Mejia, Liliana Moreno & Margarita Velazco. (2023) Spontaneous remission without treatment of acute myelomonocytic leukemia associated with COVID-19 infection. Hematology, Transfusion and Cell Therapy.
Crossref
Nitin K. Saksena, Srinivasa Bonam Reddy, Monica Miranda-Saksena, Thyago H.S. Cardoso, Edson M.A. Silva, Juliana C. Ferreira & Wael M. Rabeh. (2023) SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1869:8, pages 166836.
Crossref
Oyahida Khatun, Mansi Sharma, Rohan Narayan & Shashank Tripathi. (2023) SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and type-I interferon induction. Cellular and Molecular Life Sciences 80:12.
Crossref
Benjamin L. Sievers, Mark T. K. Cheng, Kata Csiba, Bo Meng & Ravindra K. Gupta. (2023) SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”. Cellular & Molecular Immunology 21:2, pages 171-183.
Crossref
Roger J. Grand. (2023) SARS-CoV-2 and the DNA damage response. Journal of General Virology 104:11.
Crossref
Pan Gong, Qingtang Shen, Mingzhen Zhang, Rui Qiao, Jing Jiang, Lili Su, Siwen Zhao, Shuai Fu, Yu Ma, Linhao Ge, Yaqin Wang, Rosa Lozano-Durán, Aiming Wang, Fangfang Li & Xueping Zhou. (2023) Plant and animal positive-sense single-stranded RNA viruses encode small proteins important for viral infection in their negative-sense strand. Molecular Plant 16:11, pages 1794-1810.
Crossref
Hazel Stewart, Yongxu Lu, Sarah O’Keefe, Anusha Valpadashi, Luis Daniel Cruz-Zaragoza, Hendrik A. Michel, Samantha K. Nguyen, George W. Carnell, Nina Lukhovitskaya, Rachel Milligan, Yasmin Adewusi, Irwin Jungreis, Valeria Lulla, David A. Matthews, Stephen High, Peter Rehling, Edward Emmott, Jonathan L. Heeney, Andrew D. Davidson, James R. Edgar, Geoffrey L. Smith & Andrew E. Firth. (2023) The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity. iScience 26:11, pages 108080.
Crossref
M. Bello-Perez, J. Hurtado-Tamayo, A. Z. Mykytyn, M. M. Lamers, R. Requena-Platek, D. Schipper, D. Muñoz-Santos, J. Ripoll-Gómez, A. Esteban, P. J. Sánchez-Cordón, L. Enjuanes, B. L. Haagmans & I. Sola. (2023) SARS-CoV-2 ORF8 accessory protein is a virulence factor. mBio 14:5.
Crossref
Chun-Kit Yuen, Wan-Man Wong, Long-Fung Mak, Joy-Yan Lam, Lok-Yi Cheung, Derek Tsz-Yin Cheung, Yau-Yee Ng, Andrew Chak-Yiu Lee, Nanshan Zhong, Kwok-Yung Yuen & Kin-Hang Kok. (2023) An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models. Nature Communications 14:1.
Crossref
Marta De Angelis, Gabriele Anichini, Anna Teresa Palamara, Lucia Nencioni & Gianni Gori Savellini. (2023) Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein. Virology Journal 20:1.
Crossref
S O’Reilly. (2023) Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets. QJM: An International Journal of Medicine 116:9, pages 750-754.
Crossref
Yihua Zhang, Bowen Xin, Yinan Liu, Wenyi Jiang, Wendong Han, Jian Deng, Peihui Wang, Xiaowu Hong & Dapeng Yan. (2023) SARS-COV-2 protein NSP9 promotes cytokine production by targeting TBK1. Frontiers in Immunology 14.
Crossref
Marco Chilosi, Claudio Doglioni, Claudia Ravaglia, Sara Piciucchi, Alessandra Dubini, Lavinia Stefanizzi & Venerino Poletti. (2023) COVID-19. Biology, pathophysiology, and immunology: a pathologist view. Pathologica 115:5, pages 248-256.
Crossref
Sandy S Burkart, Darius Schweinoch, Jamie Frankish, Carola Sparn, Sandra Wüst, Christian Urban, Marta Merlo, Vladimir G Magalhães, Antonio Piras, Andreas Pichlmair, Joschka Willemsen, Lars Kaderali & Marco Binder. (2023) High-resolution kinetic characterization of the RIG-I-signaling pathway and the antiviral response. Life Science Alliance 6:10, pages e202302059.
Crossref
Elizabeth W. WellsMichael T. Parker. (2023) Regulating Select Agent Chimeras: Defining the Problem(s) Through the Lens of SARS-CoV-1/SARS-CoV-2 Chimeric Viruses. Health Security 21:5, pages 392-406.
Crossref
Anna Allué-Guardia, Jordi B. Torrelles & Alex Sigal. (2023) Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease. Frontiers in Immunology 14.
Crossref
Cui Yuan, Zhenling Ma, Jiufeng Xie, Wenqing Li, Lijuan Su, Guozhi Zhang, Jun Xu, Yaru Wu, Min Zhang & Wei Liu. (2023) The role of cell death in SARS-CoV-2 infection. Signal Transduction and Targeted Therapy 8:1.
Crossref
Santiago Justo Arevalo, Adriana Castillo-Chávez, Carmen Sofia Uribe Calampa, Daniela Zapata Sifuentes, César J. Huallpa, Gianfranco Landa Bianchi, Romina Garavito-Salini Casas, Mauro Quiñones Aguilar & Roberto Pineda Chavarría. (2023) What do we know about the function of SARS-CoV-2 proteins?. Frontiers in Immunology 14.
Crossref
Dianqi Zhang, Likai Ji, Xu Chen, Yumin He, Yijie Sun, Li Ji, Tiancheng Zhang, Quan Shen, Xiaochun Wang, Yan Wang, Shixing Yang, Wen Zhang & Chenglin Zhou. (2023) SARS-CoV-2 Nsp15 suppresses type I interferon production by inhibiting IRF3 phosphorylation and nuclear translocation. iScience 26:9, pages 107705.
Crossref
Harrison C. Bergeron, Matthew R. Hansen & Ralph A. Tripp. (2023) Interferons—Implications in the Immune Response to Respiratory Viruses. Microorganisms 11:9, pages 2179.
Crossref
Charles E. Samuel. (2023) Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease. Journal of Biological Chemistry 299:8, pages 104960.
Crossref
Michela Biancolella, Vito Luigi Colona, Lucio Luzzatto, Jessica Lee Watt, Giorgio Mattiuz, Silvestro G. Conticello, Naftali Kaminski, Ruty Mehrian-Shai, Albert I. Ko, Gregg S. Gonsalves, Vasilis Vasiliou, Giuseppe Novelli & Juergen K. V. Reichardt. (2023) COVID-19 annual update: a narrative review. Human Genomics 17:1.
Crossref
Elena Krachmarova, Peicho Petkov, Elena Lilkova, Nevena Ilieva, Miroslav Rangelov, Nadezhda Todorova, Kristina Malinova, Rossitsa Hristova, Genoveva Nacheva, Anastas Gospodinov & Leandar Litov. (2023) Insights into the SARS-CoV-2 ORF6 Mechanism of Action. International Journal of Molecular Sciences 24:14, pages 11589.
Crossref
Gianni Gori Savellini, Gabriele Anichini & Maria Grazia Cusi. (2023) SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells. Virus Research 332, pages 199134.
Crossref
Xiaoyuan Lin, Zhou Sha, Jakob Trimpert, Dusan Kunec, Chen Jiang, Yan Xiong, Binbin Xu, Zhenglin Zhu, Weiwei Xue & Haibo Wu. (2023) The NSP4 T492I mutation increases SARS-CoV-2 infectivity by altering non-structural protein cleavage. Cell Host & Microbe 31:7, pages 1170-1184.e7.
Crossref
Minghua Li, Kasirajan Ayyanathan, Mark Dittmar, Jesse Miller, Iulia Tapescu, Jae Seung Lee, Marisa E. McGrath, Yong Xue, Sanjay Vashee, David C. Schultz, Matthew B. Frieman & Sara Cherry. (2023) SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection. mBio.
Crossref
Samantha L. Grimes, Young J. Choi, Anoosha Banerjee, Gabriel Small, Jordan Anderson-Daniels, Jennifer Gribble, Andrea J. Pruijssers, Maria L. Agostini, Alexandra Abu-Shmais, Xiaotao Lu, Seth A. Darst, Elizabeth Campbell & Mark R. Denison. (2023) A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance. mBio.
Crossref
David P. Maison, Youping Deng & Mariana Gerschenson. (2023) SARS-CoV-2 and the host-immune response. Frontiers in Immunology 14.
Crossref
Ido-David Dechtman, Ran Ankory, Keren Sokolinsky, Esther Krasner, Libby Weiss & Yoav Gal. (2023) Clinically Evaluated COVID-19 Drugs with Therapeutic Potential for Biological Warfare Agents. Microorganisms 11:6, pages 1577.
Crossref
Andre Schutzer Godoy, Aline Minalli Nakamura, Alice Douangamath, Yun Song, Gabriela Dias Noske, Victor Oliveira Gawriljuk, Rafaela Sachetto Fernandes, Humberto D Muniz Pereira, Ketllyn Irene Zagato Oliveira, Daren Fearon, Alexandre Dias, Tobias Krojer, Michael Fairhead, Alisa Powell, Louise Dunnet, Jose Brandao-Neto, Rachael Skyner, Rod Chalk, Dávid Bajusz, Miklós Bege, Anikó Borbás, György Miklós Keserű, Frank von Delft & Glaucius Oliva. (2023) Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease. Nucleic Acids Research 51:10, pages 5255-5270.
Crossref
Marina Escalera-Zamudio, Sergei L Kosakovsky Pond, Natalia Martínez de la Viña, Bernardo Gutiérrez, Rhys P D Inward, Julien Thézé, Lucy van Dorp, Hugo G Castelán-Sánchez, Thomas A Bowden, Oliver G Pybus & Ruben J G Hulswit. (2023) Identification of Evolutionary Trajectories Shared across Human Betacoronaviruses. Genome Biology and Evolution 15:6.
Crossref
Chandan Bhowal, Sayak Ghosh, Debapriya Ghatak & Rudranil De. (2022) Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight. Molecular and Cellular Biochemistry 478:6, pages 1325-1343.
Crossref
Kuan Feng, Hui‐Jiao Zhang, Yuan‐Qin Min, Min Zhou, Fei Deng, Hua‐Lin Wang, Pei‐Qing Li & Yun‐Jia Ning. (2023) SARS‐CoV‐2 NSP13 interacts with host IRF3, blocking antiviral immune responses. Journal of Medical Virology 95:6.
Crossref
Xuan Liu, Lunzhi Yuan, Jijing Chen, Yali Zhang, Peiwen Chen, Ming Zhou, Jiaxuan Xie, Jian Ma, Jianzhong Zhang, Kun Wu, Qiyi Tang, Quan Yuan, Huachen Zhu, Tong Cheng, Yi Guan, Gang Liu & Ningshao Xia. (2023) Antiviral Nanobiologic Therapy Remodulates Innate Immune Responses to Highly Pathogenic Coronavirus. Advanced Science 10:17.
Crossref
Vita Petrone, Marialaura Fanelli, Martina Giudice, Nicola Toschi, Allegra Conti, Christian Maracchioni, Marco Iannetta, Claudia Resta, Chiara Cipriani, Martino Tony Miele, Francesca Amati, Massimo Andreoni, Loredana Sarmati, Paola Rogliani, Giuseppe Novelli, Enrico Garaci, Guido Rasi, Paola Sinibaldi-Vallebona, Antonella Minutolo, Claudia Matteucci, Emanuela Balestrieri & Sandro Grelli. (2023) Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity. Frontiers in Microbiology 14.
Crossref
Xianghui Liang, Xiaoyuan Chen, Junqiong Zhai, Xiaobing Li, Xu Zhang, Zhipeng Zhang, Ping Zhang, Xiao Wang, Xinyuan Cui, Hai Wang, Niu Zhou, Zu-Jin Chen, Renwei Su, Fuqing Zhou, Edward C. Holmes, David M. Irwin, Rui-Ai Chen, Qian He, Ya-Jiang Wu, Chen Wang, Xue-Qing Du, Shi-Ming Peng, Wei-Jun Xie, Fen Shan, Wan-Ping Li, Jun-Wei Dai, Xuejuan Shen, Yaoyu Feng, Lihua Xiao, Wu Chen & Yongyi Shen. (2023) Pathogenicity, tissue tropism and potential vertical transmission of SARSr-CoV-2 in Malayan pangolins. PLOS Pathogens 19:5, pages e1011384.
Crossref
Sareh Kakavandi, Iman Zare, Maryam VaezJalali, Masoud Dadashi, Maryam Azarian, Abdullatif Akbari, Marzieh Ramezani Farani, Hamidreza Zalpoor & Bahareh Hajikhani. (2023) Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. Cell Communication and Signaling 21:1.
Crossref
Nitya Dubey, Tahmeena Khan, Pavan Kumar Nagar, Brijesh Singh & Anju Verma. 2023. COVID-19: Origin, Impact and Management, Part 1. COVID-19: Origin, Impact and Management, Part 1 27 46 .
Yuanyuan Yu, Bangjiang Fang, Xiao-Dong Yang & Yuejuan Zheng. (2023) One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19. Frontiers in Pharmacology 14.
Crossref
Dan Cao, Lian DuanBin Huang, Yuxian Xiong, Guoliang Zhang & Hao Huang. (2023) The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING. Science Signaling 16:783.
Crossref
Jesus Hurtado-Tamayo, Ricardo Requena-Platek, Luis Enjuanes, Melissa Bello-Perez & Isabel Sola. (2023) Contribution to pathogenesis of accessory proteins of deadly human coronaviruses. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Melinda Metzler, Rebecca George Tharyan, Kevin Klann, Katharina Grikscheit, Denisa Bojkova, Jindrich Cinatl, Georg Tascher, Sandra Ciesek & Christian Münch. (2023) SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells. Molecular & Cellular Proteomics 22:5, pages 100537.
Crossref
Kim R. Chiok, Neeraj Dhar & Arinjay Banerjee. (2023) Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns. iScience 26:5, pages 106629.
Crossref
Cody Bills, Xuping Xie & Pei-Yong Shi. (2023) The multiple roles of nsp6 in the molecular pathogenesis of SARS-CoV-2. Antiviral Research 213, pages 105590.
Crossref
Tsung-Hsien Chen, Chia-Jung Chang & Peir-Haur Hung. (2023) Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder. International Journal of Molecular Sciences 24:9, pages 8034.
Crossref
Damariz Marín-Palma, Jorge H. Tabares-Guevara, María I. Zapata-Cardona, Wildeman Zapata-Builes, Natalia Taborda, Maria T. Rugeles & Juan C. Hernandez. (2023) PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication in vitro. Frontiers in Immunology 14.
Crossref
Gene D. Godbold, F. Curtis Hewitt, Anthony D. Kappell, Matthew B. Scholz, Stacy L. Agar, Todd J. Treangen, Krista L. Ternus, Jonas B. Sandbrink & Gregory D. Koblentz. (2023) Improved understanding of biorisk for research involving microbial modification using annotated sequences of concern. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Beatriz Escudero-Pérez, Philip Lawrence & Javier Castillo-Olivares. (2023) Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection. Frontiers in Immunology 14.
Crossref
Yi-Yang Pan, Liu-Can Wang, Feng Yang & Min Yu. (2023) Interferon-lambda: New functions on intestinal symptoms in COVID-19. World Journal of Gastroenterology 29:13, pages 1942-1954.
Crossref
Iván Martínez-Espinoza & Antonieta Guerrero-Plata. (2023) Current Landscape of IFN-λ: Induction, Inhibition, and Potential Clinical Applications to Treat Respiratory Viral Infections. ImmunoHorizons 7:4, pages 265-272.
Crossref
L. A. Oleinik, P. G. Madonov & M. B. Pykhtina. (2023) Potential of Interferon Lambda as an Inhibitor of SARS-CoV-2. Molecular Biology 57:2, pages 291-298.
Crossref
Shahrzad Ahmadi, Mahsa Bazargan, Reza Elahi & Abdolreza Esmaeilzadeh. (2023) Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches. Molecular Immunology 156, pages 10-19.
Crossref
Jung-Hyun Lee, Lennart Koepke, Frank Kirchhoff & Konstantin M. J. Sparrer. (2022) Interferon antagonists encoded by SARS-CoV-2 at a glance. Medical Microbiology and Immunology 212:2, pages 125-131.
Crossref
Jian Deng, Sheng‐Nan Zheng, Yang Xiao, Mei‐Ling Nan, Jing Zhang, Lulu Han, Yi Zheng, Yanying Yu, Qiang Ding, Chengjiang Gao & Pei‐Hui Wang. (2023) SARS‐CoV‐2 NSP8 suppresses type I and III IFN responses by modulating the RIG‐I/MDA5, TRIF, and STING signaling pathways. Journal of Medical Virology 95:4.
Crossref
Iogann Tolbatov, Alessandro Marrone, William Shepard, Lorenzo Chiaverini, Mousumi Upadhyay Kahaly, Diego La Mendola, Tiziano Marzo & Lidia Ciccone. (2023) Inorganic Drugs as a Tool for Protein Structure Solving and Studies on Conformational Changes. Chemistry – A European Journal 29:16.
Crossref
Wei Zeng, Jingping Ren, Gan Yang, Changsheng Jiang, Ling Dong, Qi Sun, Yaofang Hu, Wentao Li & Qigai He. (2023) Porcine Epidemic Diarrhea Virus and Its nsp14 Suppress ER Stress Induced GRP78. International Journal of Molecular Sciences 24:5, pages 4936.
Crossref
Bryan Alejandro Espinosa-Rodriguez, Aissa Michelle Nieto-Moreno, Jose Luis Gonzalez Llerena, Tania Alejandra Rico-Torres, Pilar Carranza-Rosales, Luis Fernando Mendez-Lopez & Isaias Balderas-Renteria. (2023) Antidiabetic Drugs and their Potential Use in COVID-19: A Mechanistic Approach. Endocrine, Metabolic & Immune Disorders - Drug Targets 23:3, pages 255-272.
Crossref
Phillip D. Monk, Jody L. Brookes, Victoria J. Tear, Toby N. Batten, Marcin Mankowski, Tatjana Adzic-Vukicevic, Michael G. Crooks, Davinder P.S. Dosanjh, Monica Kraft, Christopher E. Brightling, Felicity J. Gabbay, Stephen T. Holgate, Ratko Djukanovic & Tom M.A. Wilkinson. (2023) Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study. ERJ Open Research 9:2, pages 00605-2022.
Crossref
Arutha Kulasinghe, Ning Liu, Chin Wee Tan, James Monkman, Jane E. Sinclair, Dharmesh D. Bhuva, David Godbolt, Liuliu Pan, Andy Nam, Habib Sadeghirad, Kei Sato, Gianluigi Li Bassi, Ken O'Byrne, Camila Hartmann, Anna Flavia Ribeiro dos Santos Miggiolaro, Gustavo Lenci Marques, Lidia Zytynski Moura, Derek Richard, Mark Adams, Lucia de Noronha, Cristina Pellegrino Baena, Jacky Y. Suen, Rakesh Arora, Gabrielle T. Belz, Kirsty R. Short, Melissa J. Davis, Fernando Souza‐Fonseca Guimaraes & John F. Fraser. (2022) Transcriptomic profiling of cardiac tissues from SARS‐CoV ‐2 patients identifies DNA damage . Immunology 168:3, pages 403-419.
Crossref
Mohamad HamadDana M.H. AlKhamachLujain Majed AlsayadiSirin Abdulkafi SarhanBalsam Qubais SaeedMarina SokovicTaibi Ben HaddaSameh S.M. Soliman. (2023) Alpha to Omicron (Variants of Concern): Mutation Journey, Vaccines, and Therapy. Viral Immunology 36:2, pages 83-100.
Crossref
Jian Deng, Yi Zheng, Sheng‐Nan Zheng, Mei‐Ling Nan, Lulu Han, Jing Zhang, Yunyun Jin, Ji‐An Pan, Chengjiang Gao & Pei‐Hui Wang. (2023) SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathways. Journal of Medical Virology 95:3.
Crossref
Alexander A. Mironov, Maksim A. Savin & Galina V. Beznoussenko. (2023) COVID-19 Biogenesis and Intracellular Transport. International Journal of Molecular Sciences 24:5, pages 4523.
Crossref
Cameron M. Harrison, Jayden M. Doster, Emily H. Landwehr, Nidhi P. Kumar, Ethan J. White, Dia C. Beachboard & Christopher C. Stobart. (2023) Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era. Microorganisms 11:2, pages 445.
Crossref
Nozomi Shiwa-Sudo, Yusuke Sakai, Naoko Iwata-Yoshikawa, Shinji Watanabe, Souichi Yamada, Yudai Kuroda, Tsukasa Yamamoto, Masayuki Shirakura, Seiichiro Fujisaki, Kaya Miyazaki, Hideka Miura, Shiho Nagata, Shuetsu Fukushi, Ken Maeda, Hideki Hasegawa, Tadaki Suzuki & Noriyo Nagata. (2023) Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters. Journal of Virology 97:1.
Crossref
Haoran Sun, Jasper Fuk-Woo Chan & Shuofeng Yuan. (2023) Cellular Sensors and Viral Countermeasures: A Molecular Arms Race between Host and SARS-CoV-2. Viruses 15:2, pages 352.
Crossref
Raghunath Satpathy & Sonali Acharya. (2023) Recent Advances in Novel Inhibitor Molecules Development Targeting RNA Helicase (Nonstructural Protein 13) of SARS-CoV-2: Review. Journal of Biochemical Technology 14:2, pages 66-74.
Crossref
Salma Aktar & Saiful Amin. (2023) SARS-CoV-2 mediated dysregulation in cell signaling events drives the severity of COVID-19. Virus Research 323, pages 198962.
Crossref
Jiapu ZhangJiapu Zhang. 2023. Optimization-based Molecular Dynamics Studies of SARS-CoV-2 Molecular Structures. Optimization-based Molecular Dynamics Studies of SARS-CoV-2 Molecular Structures 711 721 .
Xin Chen, Ke Chen, Zhaoyong Zhang, Peilan Wei, Lu Zhang, Yunxia Xu, Qili Lun, Yanhong Ma, Fang Wu, Ying Zhang, Yanqun Wang, Jincun Zhao, Yaoqi Zhou, Jian Zhan & Wei Xu. (2022) Investigating Derivatives of Tanshinone IIA Sulfonate Sodium and Chloroxine for Their Inhibition Activities against the SARS-CoV-2 Papain-like Protease. ACS Omega 7:51, pages 48416-48426.
Crossref
Afzal Sheikh, He Huang, Sultana Parvin, Mohammad Badruzzaman, Tofayel Ahamed, Ekhtear Hossain, Iri Sato Baran & Zahangir Alam Saud. (2022) A multi-population-based genomic analysis uncovers unique haplotype variants and crucial mutant genes in SARS-CoV-2. Journal of Genetic Engineering and Biotechnology 20:1, pages 149.
Crossref
Sin-Yee Fung, Kam-Leung Siu, Huayue Lin, Ching-Ping Chan, Man Lung Yeung & Dong-Yan Jin. (2022) SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1. Cell & Bioscience 12:1.
Crossref
Matthew C. Pahl, Carole Le Coz, Chun Su, Prabhat Sharma, Rajan M. Thomas, James A. Pippin, Emylette Cruz Cabrera, Matthew E. Johnson, Michelle E. Leonard, Sumei Lu, Alessandra Chesi, Kathleen E. Sullivan, Neil Romberg, Struan F. A. Grant & Andrew D. Wells. (2022) Implicating effector genes at COVID-19 GWAS loci using promoter-focused Capture-C in disease-relevant immune cell types. Genome Biology 23:1.
Crossref
Milad Zandi, Maryam Shafaati, Davood Kalantar-Neyestanaki, Hossein Pourghadamyari, Mona Fani, Saber Soltani, Hassan Kaleji & Samaneh Abbasi. (2022) The role of SARS-CoV-2 accessory proteins in immune evasion. Biomedicine & Pharmacotherapy 156, pages 113889.
Crossref
Pak‐Hin Hinson Cheung, Zi‐Wei Ye, Wai‐Yin Lui, Chon Phin Ong, Pearl Chan, Tak‐Wang Terence Lee, Tze‐Tung Tang, Tin‐Long Yuen, Sin‐Yee Fung, Yun Cheng, Ching‐Ping Chan, Chi‐Ping Chan & Dong‐Yan Jin. (2022) Production of single‐cycle infectious SARS‐CoV‐2 through a trans‐complemented replicon. Journal of Medical Virology 94:12, pages 6078-6090.
Crossref
Yongxu Lu, Hendrik A. Michel, Pei-Hui Wang & Geoffrey L. Smith. (2022) Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins. Frontiers in Microbiology 13.
Crossref
Deepika Saini, Kumud Madan & Shilpi Chauhan. (2022) Screening of Phytoconstituents from Traditional Plants against SARSCoV- 2 using Molecular Docking Approach. Letters in Drug Design & Discovery 19:11, pages 1022-1038.
Crossref
Yuksel Cetin, Seyma Aydinlik, Aysen Gungor, Tugce Kan, Timucin Avsar & Serdar Durdagi. (2022) Review on In Silico Methods, High-throughput Screening Techniques, and Cell Culture Based In Vitro Assays for SARS-CoV-2 . Current Medicinal Chemistry 29:38, pages 5925-5948.
Crossref
Amul S. Bahl, Vipin Kumar Verma, Jagriti Bhatia & Dharamvir Singh Arya. (2022) Integrating in silico and in vivo approach for investigating the role of polyherbal oil in prevention and treatment of COVID-19 infection. Chemico-Biological Interactions 367, pages 110179.
Crossref
Lulu Han, Yi Zheng, Jian Deng, Mei‐Ling Nan, Yang Xiao, Meng‐Wei Zhuang, Jing Zhang, Wei Wang, Chengjiang Gao & Pei‐Hui Wang. (2022) SARS‐CoV‐2 ORF10 antagonizes STING‐dependent interferon activation and autophagy. Journal of Medical Virology 94:11, pages 5174-5188.
Crossref
Yang Liu, Jian Rao, Yingjie Mi, Lan Chen, Lijuan Feng, Qi Li, Jianing Geng, Xianguang Yang, Xiangjiang Zhan, Lili Ren, Jinfeng Chen & Xiaoming Zhang. (2022) SARS-CoV-2 RNAs are processed into 22-nt vsRNAs in Vero cells. Frontiers in Immunology 13.
Crossref
Nenavath Gopal Naik, See-Chi Lee, Beatriz H. S. Veronese, Zhe Ma & Zsolt Toth. (2022) Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway. Microbiology Spectrum 10:5.
Crossref
Sarah Cristina Gozzi-Silva, Luana de Mendonça Oliveira, Ricardo Wesley Alberca, Natalli Zanete Pereira, Fábio Seiti Yoshikawa, Anna Julia Pietrobon, Tatiana Mina Yendo, Milena Mary de Souza Andrade, Yasmim Alefe Leuzzi Ramos, Cyro Alves Brito, Emily Araujo Oliveira, Danielle Rosa Beserra, Raquel Leão Orfali, Valéria Aoki, Alberto Jose da Silva Duarte & Maria Notomi Sato. (2022) Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients. Cells 11:21, pages 3359.
Crossref
Fengwen Zhang, Trinity M. Zang, Eva M. Stevenson, Xiao Lei, Dennis C. Copertino, Talia M. Mota, Julie Boucau, Wilfredo F. Garcia-Beltran, R. Brad Jones & Paul D. Bieniasz. (2022) Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins. Proceedings of the National Academy of Sciences 119:41.
Crossref
Iogann Tolbatov, Loriano Storchi & Alessandro Marrone. (2022) Structural Reshaping of the Zinc-Finger Domain of the SARS-CoV-2 nsp13 Protein Using Bismuth(III) Ions: A Multilevel Computational Study. Inorganic Chemistry 61:39, pages 15664-15677.
Crossref
Jayanth Jeevanandam, Esackimuthu Paramasivam, Anbumathi Palanisamy, Srikanth Raghavendran & Saraswathi Nambiappan Thangavel. (2022) Molecular Insights on Bioactive Compounds against Covid-19: A Network Pharmacological and Computational Study. Current Computer-Aided Drug Design 18:6, pages 425-439.
Crossref
Tai-Wei Li, Adam D. Kenney, Jun-Gyu Park, Guillaume N. Fiches, Helu Liu, Dawei Zhou, Ayan Biswas, Weiqiang Zhao, Jianwen Que, Netty Santoso, Luis Martinez-Sobrido, Jacob S. Yount & Jian Zhu. (2022) SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling. Frontiers in Immunology 13.
Crossref
Ana C. Puhl, Giovanni F. Gomes, Samara Damasceno, Ethan J. Fritch, James A. Levi, Nicole J. Johnson, Frank Scholle, Lakshmanane Premkumar, Brett L. Hurst, Felipe Lee-Montiel, Flavio P. Veras, Sabrina S. Batah, Alexandre T. Fabro, Nathaniel J. Moorman, Boyd L. Yount, Rebekah J. Dickmander, Ralph S. Baric, Kenneth H. Pearce, Fernando Q. Cunha, José C. Alves-Filho, Thiago M. Cunha & Sean Ekins. (2022) Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice. ACS Omega 7:36, pages 31935-31944.
Crossref
Jo-Ning Hung, Di Ngoc Kha Vo, Ha Phan Thanh Ho & Ming-Han Tsai. (2022) PEDOT:PSS in Solution Form Exhibits Strong Potential in Inhibiting SARS-CoV-2 Infection of the Host Cells by Targeting Viruses and Also the Host Cells. Biomacromolecules 23:9, pages 3535-3548.
Crossref
Zheng Yao Low, Nur Zawanah Zabidi, Ashley Jia Wen Yip, Ashwini Puniyamurti, Vincent T. K. Chow & Sunil K. Lal. (2022) SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion. Viruses 14:9, pages 1991.
Crossref
Takaya Ichikawa, Shiho Torii, Hikoyu Suzuki, Akio Takada, Satoshi Suzuki, Masahide Nakajima, Akihito Tampo & Yasutaka Kakinoki. (2022) Mutations in the nonstructural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in patients with COVID-19. International Journal of Infectious Diseases 122, pages 123-129.
Crossref
Jozefien Declercq, Elisabeth De Leeuw & Bart N. Lambrecht. (2022) Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent. Cytokine 157, pages 155934.
Crossref
Priyanka Singh, Sanjay Singh Negi, Anudita Bhargava, Vara Prasad Kolla & Ripu Daman Arora. (2022) A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic. Archives of Medical Research 53:6, pages 574-584.
Crossref
Mingming Wang, Yue Zhao, Juan Liu & Ting Li. (2022) SARS‐CoV‐2 modulation of RIG‐I‐MAVS signaling: Potential mechanisms of impairment on host antiviral immunity and therapeutic approaches. MedComm – Future Medicine 1:2.
Crossref
Fang-Shu Shi, Yin Yu, Ya-Li Li, Lilan Cui, Zhuangzhuang Zhao, Mi Wang, Bin Wang, Rong Zhang & Yao-Wei Huang. (2022) Expression Profile and Localization of SARS-CoV-2 Nonstructural Replicase Proteins in Infected Cells. Microbiology Spectrum 10:4.
Crossref
Mansoor Khaledi, Fatemeh Sameni, Sheida Yahyazade, Maedeh Radandish, Parviz Owlia, Nader Bagheri, Hamed Afkhami, Mohamad Mahjoor, Zahra Esmaelpour, Maryam Kohansal & Farzad Aghaei. (2022) COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy. Frontiers in Medicine 9.
Crossref
Nan Zhang, Siyuan Wang & Catherine C.L. Wong. (2022) Proteomics research of SARS-CoV-2 and COVID-19 disease. Medical Review 2:4, pages 427-445.
Crossref
Mariel Kleer, Rory P. Mulloy, Carolyn-Ann Robinson, Danyel Evseev, Maxwell P. Bui-Marinos, Elizabeth L. Castle, Arinjay Banerjee, Samira Mubareka, Karen Mossman & Jennifer A. Corcoran. (2022) Human coronaviruses disassemble processing bodies. PLOS Pathogens 18:8, pages e1010724.
Crossref
Nicholas H. Moeller, Kellan T. Passow, Daniel A. Harki & Hideki Aihara. (2022) SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3′-Deoxy-3′,4′-didehydro-cytidine Nucleotide from RNA. Viruses 14:8, pages 1790.
Crossref
C D Russell & S Clohisey Hendry. (2022) Defining resistance and tolerance traits in Covid-19: towards a stratified medicine approach. QJM: An International Journal of Medicine 115:8, pages 513-519.
Crossref
Farooq Rashid, Zhixun Xie, Muhammad Suleman, Abdullah Shah, Suliman Khan & Sisi Luo. (2022) Roles and functions of SARS-CoV-2 proteins in host immune evasion. Frontiers in Immunology 13.
Crossref
Ivette Karina Freyle-Román, Brigitte Ofelia Peña-López & Bladimiro Rincón-Orozco. (2022) Importancia de los Interferones en la respuesta inmune antiviral contra SARS-CoV-2. Salud UIS 54:1.
Crossref
Hin Chu, Yuxin Hou, Dong Yang, Lei Wen, Huiping Shuai, Chaemin Yoon, Jialu Shi, Yue Chai, Terrence Tsz-Tai Yuen, Bingjie Hu, Cun Li, Xiaoyu Zhao, Yixin Wang, Xiner Huang, Kin Shing Lee, Cuiting Luo, Jian-Piao Cai, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Anna Jinxia Zhang, Shuofeng Yuan, Ko-Yung Sit, Dominic Chi-Chung Foo, Wing-Kuk Au, Kenneth Kak-Yuen Wong, Jie Zhou, Kin-Hang Kok, Dong-Yan Jin, Jasper Fuk-Woo Chan & Kwok-Yung Yuen. (2022) Coronaviruses exploit a host cysteine-aspartic protease for replication. Nature.
Crossref
Ingrid Fricke-Galindo, Alfonso Martínez-Morales, Leslie Chávez-Galán, Ranferi Ocaña-Guzmán, Ivette Buendía-Roldán, Gloria Pérez-Rubio, Rafael de Jesus Hernández-Zenteno, Abigail Verónica-Aguilar, Aimé Alarcón-Dionet, Hiram Aguilar-Duran, Ilse Adriana Gutiérrez-Pérez, Oscar Zaragoza-García, Jesús Alanis-Ponce, Angel Camarena, Brandon Bautista-Becerril, Karol J. Nava-Quiroz, Mayra Mejía, Iris Paola Guzmán-Guzmán & Ramcés Falfán-Valencia. (2022) IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19. Frontiers in Immunology 13.
Crossref
Pengfei Chen, Junrui Zhu, Jiarong Yu, Ruilin Liu, Mengqin Lao, Lingxue Yu, Fei Gao, Yifeng Jiang, Changlong Liu, Wu Tong, Huili Liu, Guangzhi Tong & Yanjun Zhou. (2022) Porcine epidemic diarrhea virus strain FJzz1 infection induces type I/III IFNs production through RLRs and TLRs-mediated signaling. Frontiers in Immunology 13.
Crossref
Doris Loh & Russel J. Reiter. (2022) Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19. International Journal of Molecular Sciences 23:15, pages 8122.
Crossref
Aurélie Deroubaix & Anna Kramvis. (2022) Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Shujuan Jin & Mengjiao Zhang. (2022) Insights into Coronavirus Papain-like Protease Structure, Function and Inhibitors. Protein & Peptide Letters 29:7, pages 574-583.
Crossref
Alisher Abdullaev, Abrorjon Abdurakhimov, Zebinisa Mirakbarova, Shakhnoza Ibragimova, Vladimir Tsoy, Sharofiddin Nuriddinov, Dilbar Dalimova, Shahlo Turdikulova & Ibrokhim Abdurakhmonov. (2022) Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan. PLOS ONE 17:6, pages e0270314.
Crossref
Qi Liu, Sensen Chi, Kostyantyn Dmytruk, Olena Dmytruk & Shuai Tan. (2022) Coronaviral Infection and Interferon Response: The Virus-Host Arms Race and COVID-19. Viruses 14:7, pages 1349.
Crossref
Wen-Lin Su, Chia-Chao Wu, Shu-Fang Vivienne Wu, Mei-Chen Lee, Min-Tser Liao, Kuo-Cheng Lu & Chien-Lin Lu. (2022) A Review of the Potential Effects of Melatonin in Compromised Mitochondrial Redox Activities in Elderly Patients With COVID-19. Frontiers in Nutrition 9.
Crossref
Yu-An Kung, Kuo-Ming Lee, Huan-Jung Chiang, Sheng-Yu Huang, Chung-Jung Wu & Shin-Ru Shih. (2022) Molecular Virology of SARS-CoV-2 and Related Coronaviruses. Microbiology and Molecular Biology Reviews 86:2.
Crossref
Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo & Maria Grazia Cusi. (2022) Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion. Viruses 14:6, pages 1273.
Crossref
Ana C. Puhl, Giovanni F. Gomes, Samara Damasceno, Andre S. Godoy, Gabriela D. Noske, Aline M. Nakamura, Victor O. Gawriljuk, Rafaela S. Fernandes, Natalia Monakhova, Olga Riabova, Thomas R. Lane, Vadim Makarov, Flavio P. Veras, Sabrina S. Batah, Alexandre T. Fabro, Glaucius Oliva, Fernando Q. Cunha, José C. Alves-Filho, Thiago M. Cunha & Sean Ekins. (2022) Pyronaridine Protects against SARS-CoV-2 Infection in Mouse. ACS Infectious Diseases 8:6, pages 1147-1160.
Crossref
Reem Hoteit & Hadi M. Yassine. (2022) Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences. Vaccines 10:6, pages 919.
Crossref
Mariem Znaidia, Caroline Demeret, Sylvie van der Werf & Anastassia V. Komarova. (2022) Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options. Viruses 14:6, pages 1247.
Crossref
Paloma Troyano-Hernáez, Roberto Reinosa & África Holguín. (2022) Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins. International Journal of Molecular Sciences 23:12, pages 6394.
Crossref
Alberto Rubio-Casillas, Elrashdy M. Redwan & Vladimir N. Uversky. (2022) SARS-CoV-2: A Master of Immune Evasion. Biomedicines 10:6, pages 1339.
Crossref
Simone Cesaro, Per Ljungman, Malgorzata Mikulska, Hans H. Hirsch, Marie von Lilienfeld-Toal, Catherine Cordonnier, Sylvain Meylan, Varun Mehra, Jan Styczynski, Francesco Marchesi, Caroline Besson, Fausto Baldanti, Raul Cordoba Masculano, Gernot Beutel, Herman Einsele, Elie Azoulay, Johan Maertens, Rafael de la Camara, Marie von Lilienfeld-Toal, Rafael de la Camara & Livio Pagano. (2022) Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia 36:6, pages 1467-1480.
Crossref
Chunye Zhang & Ming Yang. (2022) Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules. International Journal of Molecular Sciences 23:11, pages 6083.
Crossref
Asmaa Hachim, Haogao Gu, Otared Kavian, Masashi Mori, Mike Y. W. Kwan, Wai Hung Chan, Yat Sun Yau, Susan S. Chiu, Owen T. Y. Tsang, David S. C. Hui, Chris K. P. Mok, Fionn N. L. Ma, Eric H. Y. Lau, Gaya K. Amarasinghe, Abraham J. Qavi, Samuel M. S. Cheng, Leo L. M. Poon, J. S. Malik Peiris, Sophie A. Valkenburg & Niloufar Kavian. (2022) SARS-CoV-2 accessory proteins reveal distinct serological signatures in children. Nature Communications 13:1.
Crossref
Jiayi Chen, Zixin Lu, Xiuwen Yang, Yezhen Zhou, Jing Gao, Shihao Zhang, Shan Huang, Jintai Cai, Jianhai Yu, Wei Zhao & Bao Zhang. (2022) Severe Acute Respiratory Syndrome Coronavirus 2 ORF8 Protein Inhibits Type I Interferon Production by Targeting HSP90B1 Signaling. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Yoichi Miyamoto, Yumi Itoh, Tatsuya Suzuki, Tomohisa Tanaka, Yusuke Sakai, Masaru Koido, Chiaki Hata, Cai-Xia Wang, Mayumi Otani, Kohji Moriishi, Taro Tachibana, Yoichiro Kamatani, Yoshihiro Yoneda, Toru Okamoto & Masahiro Oka. (2022) SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication. Communications Biology 5:1.
Crossref
Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, Sanaz Hassani, Michal Sekrecki, Hanna Nowicka, Natalia Lopacinska, Arta Olya, Katarzyna Kluzek, Joanna Wesoly & Hans A. R. Bluyssen. (2022) Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy. Frontiers in Immunology 13.
Crossref
Pengcheng Wang, Xianwei Wang, Xing Liu, Meng Sun, Xiao Liang, Juan Bai & Ping Jiang. (2022) Natural Compound ZINC12899676 Reduces Porcine Epidemic Diarrhea Virus Replication by Inhibiting the Viral NTPase Activity. Frontiers in Pharmacology 13.
Crossref
Saba R. Aliyari, Natalie Quanquin, Olivier Pernet, Shilei Zhang, Lulan Wang & Genhong Cheng. (2022) The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2. Pathogens 11:5, pages 538.
Crossref
Yiran Wang, Mandi Wu, Yichen Li, Ho Him Yuen & Ming-Liang He. (2022) The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy. Journal of Biomedical Science 29:1.
Crossref
Farah Anjum, Taj Mohammad, Purva Asrani, Alaa Shafie, Shailza Singh, Dharmendra Kumar Yadav, Vladimir N. Uversky & Md Imtaiyaz Hassan. (2022) Identification of intrinsically disorder regions in non-structural proteins of SARS-CoV-2: New insights into drug and vaccine resistance. Molecular and Cellular Biochemistry 477:5, pages 1607-1619.
Crossref
Elizabeth R. Vanderwall, Kaitlyn A. Barrow, Lucille M. Rich, David F. Read, Cole Trapnell, Oghenemega Okoloko, Steven F. Ziegler, Teal S. Hallstrand, Maria P. White & Jason S. Debley. (2022) Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication. Scientific Reports 12:1.
Crossref
Jiyao Chen, Zhuang Li, Jiahui Guo, Shangen Xu, Junwei Zhou, Qian Chen, Xue Tong, Dang Wang, Guiqing Peng, Liurong Fang & Shaobo Xiao. (2022) SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog. Journal of Virology 96:8.
Crossref
Franziska Ramm, Srujan K. Dondapati, Hoai Anh Trinh, Dana Wenzel, Ruben M. Walter, Anne Zemella & Stefan Kubick. (2022) The Potential of Eukaryotic Cell-Free Systems as a Rapid Response to Novel Zoonotic Pathogens: Analysis of SARS-CoV-2 Viral Proteins. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Xiaoman Liu, Liang WeiFengwen XuFei ZhaoYu HuangZhangling Fan, Shan MeiYamei HuLinxuan ZhaiJustin GuoAihua Zheng, Shan Cen, Chen Liang & Fei Guo. (2022) SARS-CoV-2 spike protein–induced cell fusion activates the cGAS-STING pathway and the interferon response. Science Signaling 15:729.
Crossref
Zhao-Zhong Chong & Nizar Souayah. (2022) SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies. Current Medicinal Chemistry 29:12, pages 2051-2074.
Crossref
Nasim Kheshtchin, Parisa Bakhshi, Samaneh Arab & Maryam Nourizadeh. (2022) Immunoediting in SARS-CoV-2: Mutual relationship between the virus and the host. International Immunopharmacology 105, pages 108531.
Crossref
Biswajit Biswas, Shagnik Chattopadhyay, Sayantee Hazra, Arman Kunwar Hansda & Ritobrata Goswami. (2022) COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines. Inflammation Research 71:4, pages 377-396.
Crossref
Mohammad Fallahzadeh, Mohamad A. Pourhoseingholi, Masoud G. Boroujeni, Sajad Besharati, Masoud Mardani, Minoosh Shabani, Shervin Shokouhi, Mahdi Amirdosara, Mohammadreza Hajiesmaeili, Latif Gachkar, Baran Roshan, Masoud Zangi, Golshan Mirmomeni, Seyed S. N. Irvani & Ilad Alavi Darazam. (2021) Study of the effects of interferon β−1a on hospitalized patients with COVID‐19: SBMU Taskforce on the COVIFERON study. Journal of Medical Virology 94:4, pages 1488-1493.
Crossref
Ana C. Puhl, Thomas R. Lane, Fabio Urbina & Sean Ekins. (2022) The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19. Frontiers in Drug Discovery 2.
Crossref
Qian Zhang, Paul Bastard, Adem Karbuz, Adrian Gervais, Ahmad Abou Tayoun, Alessandro Aiuti, Alexandre Belot, Alexandre Bolze, Alexandre Gaudet, Anastasiia Bondarenko, Zhiyong Liu, András N. Spaan, Andrea Guennoun, Andres Augusto Arias, Anna M. Planas, Anna Sediva, Anna Shcherbina, Anna-Lena Neehus, Anne Puel, Antoine Froidure, Antonio Novelli, Aslınur Özkaya Parlakay, Aurora Pujol, Aysun Yahşi, Belgin Gülhan, Benedetta Bigio, Bertrand Boisson, Beth A. Drolet, Carlos Andres Arango Franco, Carlos Flores, Carlos Rodríguez-Gallego, Carolina Prando, Catherine M. Biggs, Charles-Edouard Luyt, Clifton L. Dalgard, Cliona O’Farrelly, Daniela Matuozzo, David Dalmau, David S. Perlin, Davood Mansouri, Diederik van de Beek, Donald C. Vinh, Elena Dominguez-Garrido, Elena W. Y. Hsieh, Emine Hafize Erdeniz, Emmanuelle Jouanguy, Esra Şevketoglu, Estelle Talouarn, Eugenia Quiros-Roldan, Evangelos Andreakos, Eystein Husebye, Fahad Alsohime, Filomeen Haerynck, Giorgio Casari, Giuseppe Novelli, Gökhan Aytekin, Guillaume Morelle, Gulsum Alkan, Gulsum Iclal Bayhan, Hagit Baris Feldman, Helen C. Su, Horst von Bernuth, Igor Resnick, Ingrid Bustos, Isabelle Meyts, Isabelle Migeotte, Ivan Tancevski, Jacinta Bustamante, Jacques Fellay, Jamila El Baghdadi, Javier Martinez-Picado, Jean-Laurent Casanova, Jeremie Rosain, Jeremy Manry, Jie Chen, John Christodoulou, Jonathan Bohlen, José Luis Franco, Juan Li, Juan Manuel Anaya, Julian Rojas, Junqiang Ye, K. M. Furkan Uddin, Kadriye Kart Yasar, Kai Kisand, Keisuke Okamoto, Khalil Chaïbi, Kristina Mironska, László Maródi, Laurent Abel, Laurent Renia, Lazaro Lorenzo, Lennart Hammarström, Lisa F. P. Ng, Lluis Quintana-Murci, Lucia Victoria Erazo, Luigi D. Notarangelo, Luis Felipe Reyes, Luis M. Allende, Luisa Imberti, Majistor Raj Luxman Maglorius Renkilaraj, Marcela Moncada-Velez, Marie Materna, Mark S. Anderson, Marta Gut, Marwa Chbihi, Masato Ogishi, Melike Emiroglu, Mikko R. J. Seppänen, Mohammed J. Uddin, Mohammed Shahrooei, Natalie Alexander, Nevin Hatipoglu, Nico Marr, Nihal Akçay, Oksana Boyarchuk, Ondrej Slaby, Ozge Metin Akcan, Peng Zhang, Pere Soler-Palacín, Peter K. Gregersen, Petter Brodin, Pierre Garçon, Pierre-Emmanuel Morange, Qiang Pan-Hammarström, Qinhua Zhou, Quentin Philippot, Rabih Halwani, Rebeca Perez de Diego, Romain Levy, Rui Yang, Şadiye Kübra Tüter Öz, Saleh Al Muhsen, Saliha Kanık-Yüksek, Sara Espinosa-Padilla, Sathishkumar Ramaswamy, Satoshi Okada, Sefika Elmas Bozdemir, Selma Erol Aytekin, Şemsi Nur Karabela, Sevgi Keles, Sevtap Senoglu, Shen-Ying Zhang, Sotirija Duvlis, Stefan N. Constantinescu, Stephanie Boisson-Dupuis, Stuart E. Turvey, Stuart G. Tangye, Takaki Asano, Tayfun Ozcelik, Tom Le Voyer, Tom Maniatis, Tomohiro Morio, Trine H. Mogensen, Vanessa Sancho-Shimizu, Vivien Beziat, Xavier Solanich, Yenan Bryceson, Yu-Lung Lau, Yuval Itan, Aurélie Cobat & Jean-Laurent Casanova. (2022) Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature 603:7902, pages 587-598.
Crossref
Yamei Zhang, Siobhan Gargan, Fiona M. Roche, Matthew Frieman & Nigel J. Stevenson. (2022) Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells. Viruses 14:4, pages 667.
Crossref
Douglas Jie Wen Tay, Zhe Zhang Ryan Lew, Justin Jang Hann Chu & Kai Sen Tan. (2022) Uncovering Novel Viral Innate Immune Evasion Strategies: What Has SARS-CoV-2 Taught Us?. Frontiers in Microbiology 13.
Crossref
Michela Zaffagni, Jenna M Harris, Ines L Patop, Nagarjuna Reddy Pamudurti, Sinead Nguyen & Sebastian Kadener. (2022) SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome. eLife 11.
Crossref
Duy Phuoc Tran, Yuta Taira, Takumi Ogawa, Ryoga Misu, Yoshiki Miyazawa & Akio Kitao. (2022) Inhibition of the hexamerization of SARS-CoV-2 endoribonuclease and modeling of RNA structures bound to the hexamer. Scientific Reports 12:1.
Crossref
Sameer-ul-Salam Mattoo, Seong-Jun Kim, Dae-Gyun Ahn & Jinjong Myoung. (2022) Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin. Viruses 14:3, pages 530.
Crossref
Daniel K. Beyer & Adriana Forero. (2022) Mechanisms of Antiviral Immune Evasion of SARS-CoV-2. Journal of Molecular Biology 434:6, pages 167265.
Crossref
Sean M. Cascarina & Eric D. Ross. (2022) Phase separation by the SARS-CoV-2 nucleocapsid protein: Consensus and open questions. Journal of Biological Chemistry 298:3, pages 101677.
Crossref
Soo-Jin Oh & Ok Sarah Shin. (2022) SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways. Journal of Microbiology 60:3, pages 290-299.
Crossref
Na-Eun Kim & Yoon-Jae Song. (2022) Coordinated regulation of interferon and inflammasome signaling pathways by SARS-CoV-2 proteins. Journal of Microbiology 60:3, pages 300-307.
Crossref
Faizah A. AlMalki, Salim Albukhaty, Amal A. Alyamani, Moayad N. Khalaf & Sabu Thomas. (2022) The relevant information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the five-question approach (when, where, what, why, and how) and its impact on the environment. Environmental Science and Pollution Research 30:22, pages 61430-61454.
Crossref
Devin S. M. Lewis, Joanna Ho, Savannah Wills, Anasha Kawall, Avini Sharma, Krishna Chavada, Maximilian C. C. J. C. Ebert, Stefania Evoli, Ajay Singh, Srujana Rayalam, Vicky Mody & Shashidharamurthy Taval. (2022) Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro. Scientific Reports 12:1.
Crossref
Evgenii Gusev, Alexey Sarapultsev, Liliya Solomatina & Valeriy Chereshnev. (2022) SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. International Journal of Molecular Sciences 23:3, pages 1716.
Crossref
Chao Sui, Tongyang Xiao, Shengyuan Zhang, Hongxiang Zeng, Yi Zheng, Bingyu Liu, Gang Xu, Chengjiang Gao & Zheng Zhang. (2022) SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy. The Journal of Immunology 208:3, pages 753-761.
Crossref
Yuzheng Zhou, Rong Zheng, Sixu Liu, Cyrollah Disoma, Ashuai Du, Shiqin Li, Zongpeng Chen, Zijun Dong, Yongxing Zhang, Sijia Li, Pinjia Liu, Aroona Razzaq, Xuan Chen, Yujie Liao, Siyi Tao, Yuxin Liu, Lunan Xu, Qianjun Zhang, Jian Peng, Xu Deng, Shanni Li, Taijiao Jiang & Zanxian Xia. (2022) Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation. Journal of Biological Chemistry 298:2, pages 101584.
Crossref
Eleonora Aricò, Laura Bracci, Luciano Castiello, Francesca Urbani, Jean-Laurent Casanova & Filippo Belardelli. (2022) Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19. Cytokine & Growth Factor Reviews 63, pages 23-33.
Crossref
M. du Plessis, C. Fourie, J. Riedemann, W.J.S. de Villiers & A.M. Engelbrecht. (2022) Cancer and Covid-19: Collectively catastrophic. Cytokine & Growth Factor Reviews 63, pages 78-89.
Crossref
Pierre Fillâtre, Marie-José Dufour, Sylvie Behillil, Rémi Vatan, Pascale Reusse, Alice Gabellec, Nicolas Velmans, Catherine Montagne, Sophie Geffroy Du Coudret, Edith Droumaguet, Véronique Merour, Vincent Enouf, Rodolphe Buzelé, Marion Valence, Elena Guillotel, Bertrand Gagnière, Artem Baidaliuk, Anna Zhukova, Mathieu Tourdjman, Vincent Thibault, Claire Grolhier, Charlotte Pronier, François-Xavier Lescure, Etienne Simon-Loriere, Dominique Costagliola, Sylvie Van Der Werf, Pierre Tattevin & Nicolas Massart. (2022) A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study. Clinical Microbiology and Infection 28:2, pages 298.e9-298.e15.
Crossref
Weizhu Yan, Yanhui Zheng, Xiaotao Zeng, Bin He & Wei Cheng. (2022) Structural biology of SARS-CoV-2: open the door for novel therapies. Signal Transduction and Targeted Therapy 7:1.
Crossref
Brendan L. Thoms, Jeanne Gosselin, Bonita Libman, Benjamin Littenberg & Ralph C. Budd. (2022) Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19. SN Comprehensive Clinical Medicine 4:1.
Crossref
Hong Guo-Parke, Dermot Linden, Sinéad Weldon, Joseph C. Kidney & Clifford C. Taggart. (2022) Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium. Medicina 58:1, pages 121.
Crossref
Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, Davide Finozzi, Carmelo Gentile, Michele Domenico Gentile, Roberta Marconi, Dalila Paladino, Alberto Raoss, Ilary Riedmiller, Hamza Ur Rehman, Annalisa Santini, Valerio Succetti & Lorenzo Volpini. (2022) SARS-CoV-2 and the Host Cell: A Tale of Interactions. Frontiers in Virology 1.
Crossref
Jesús Zepeda-Cervantes, Daniel Martínez-Flores, Josué Orlando Ramírez-Jarquín, Ángeles C. Tecalco-Cruz, Noé Santiago Alavez-Pérez, Luis Vaca & Rosa Elena Sarmiento-Silva. (2022) Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19. Viruses 14:1, pages 94.
Crossref
Radhakrishnan Aadhith & Parthiban Brindha Devi. (2022) Passive Immunotherapeutic Approaches for Treating Covid-19: A Comprehensive Review. International Journal Of Pharmaceutical Research And Allied Sciences 11:2, pages 52-61.
Crossref
Rudi Alberts, Sze Chun Chan, Qian-Fang MengShan HeLang Rao, Xindong Liu & Yongliang Zhang. (2022) Integration and Reanalysis of Four RNA-Seq Datasets Including BALF, Nasopharyngeal Swabs, Lung Biopsy, and Mouse Models Reveals Common Immune Features of COVID-19. Immune Network 22:3.
Crossref

Displaying 200 of 355 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.